BlackRock Inc. - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 26 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$332
-27.8%
5540.0%0.00%
Q2 2023$460
-97.5%
554
-99.0%
0.00%
Q1 2023$18,719
+25.9%
53,076
+52.7%
0.00%
Q4 2022$14,866
-17.4%
34,766
+8.6%
0.00%
Q3 2022$18,000
-25.0%
31,999
+91.6%
0.00%
Q2 2022$24,000
+500.0%
16,699
+1373.9%
0.00%
Q1 2022$4,000
-60.0%
1,1330.0%0.00%
Q4 2021$10,0001,1330.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders